Authors:
DEVILLEZ RL
SHER AM
BRENEMAN DL
ESPY PD
GARCIA CJ
MONROE EW
TANNER DJ
CUFFIE CA
Citation: Rl. Devillez et al., EFFICACY AND SAFETY OF MOMETASONE FUROATE 0.1-PERCENT ONCE-DAILY VERSUS FLUTICASONE PROPIONATE 0.005-PERCENT TWICE-DAILY IN THE MANAGEMENT OF PSORIASIS, Advances in therapy, 15(2), 1998, pp. 92-97
Authors:
LING MR
SWINYER LJ
JARRATT MT
FALO L
MONROE EW
THARP M
KALIVAS J
WEINSTEIN GD
ASARCH RG
DRAKE L
MARTIN AG
LEYDEN JJ
COOK J
PARISER DM
PARISER R
THIERS BH
LEBWOHL MG
BABEL D
STEWART DM
EAGLSTEIN WH
FALANGA V
KATZ HI
BERGFELD WF
HANIFIN JM
KANG SW
MCDONALD CJ
MUGLIA J
GOFFE BS
YOUNG MR
Citation: Mr. Ling et al., ONCE-WEEKLY FLUCONAZOLE (450 MG) FOR 4, 6, OR 9 MONTHS OF TREATMENT FOR DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 95-102
Authors:
KOO J
CUFFIE CA
TANNER DJ
BRESSINCK R
CORNELL RC
DEVILLEZ RL
EDWARDS L
BRENEMAN DL
PIACQUADIO DJ
GUZZO CA
MONROE EW
Citation: J. Koo et al., MOMETASONE FUROATE 0.1-PERCENT-SALICYLIC ACID 5-PERCENT OINTMENT VERSUS MOMETASONE FUROATE 0.1-PERCENT OINTMENT IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS - A MULTICENTER STUDY, Clinical therapeutics, 20(2), 1998, pp. 283-291
Citation: Ew. Monroe, THE CLINICAL EFFICACY OF H-1 ANTAGONISTS IN URTICARIA AND RHINITIS - REPLY, Journal of allergy and clinical immunology, 102(2), 1998, pp. 333-334
Authors:
BRENEMAN DL
DUNLAP FE
MONROE EW
SCHUPBACH CW
SHMUNES E
PHILLIPS SB
Citation: Dl. Breneman et al., DOXEPIN CREAM RELIEVES ECZEMA-ASSOCIATED PRURITUS WITHIN 15 MINUTES AND IS NOT ACCOMPANIED BY A RISK OF REBOUND UPON DISCONTINUATION, Journal of dermatological treatment, 8(3), 1997, pp. 161-168
Citation: Ew. Monroe et al., APPRAISAL OF THE VALIDITY OF HISTAMINE-INDUCED WHEAL AND FLARE TO PREDICT THE CLINICAL EFFICACY OF ANTIHISTAMINES, Journal of allergy and clinical immunology, 99(2), 1997, pp. 798-806
Citation: Ew. Monroe, AN APPRAISAL OF THE VALIDITY OF THE HISTAMINE-INDUCED WHEAT AND FLARETO PREDICT THE CLINICAL EFFICACY OF ANTIHISTAMINES (AH), Journal of allergy and clinical immunology, 99(1), 1997, pp. 1810-1810
Citation: Ew. Monroe, THE MCKENZIE VASOCONSTRICTION ASSAY - RETHINKING ITS USE FOR INTRANASAL TOPICAL CORTICOSTEROIDS, Advances in therapy, 13(4), 1996, pp. 237-243
Authors:
DRAKE LA
MILLIKAN LE
BRENEMAN DL
CHALKER D
EDWARDS L
FALLON JD
FUNICELLA T
GREENE SL
KANTOR I
KATZ HI
MAIZE JC
MONROE EW
RAIMER SS
SMITH EB
SCHUPBACH CW
SOBER A
Citation: La. Drake et al., THE ANTIPRURITIC EFFECT OF 5-PERCENT DOXEPIN CREAM IN PATIENTS WITH ECZEMATOUS DERMATITIS, Archives of dermatology, 131(12), 1995, pp. 1403-1408
Authors:
DRAKE LA
FALLON JD
SOBER A
BRENEMAN DL
BROWN RH
CHALKER D
EDWARDS L
FUNICELLA T
GREENE SL
KANTOR I
KATZ HI
MAIZE JC
MILLIKAN LE
MONROE EW
RAIMER SS
SCHUPBACH CW
SMITH EB
Citation: La. Drake et al., RELIEF OF PRURITUS IN PATIENTS WITH ATOPIC-DERMATITIS AFTER TREATMENTWITH TOPICAL DOXEPIN CREAM, Journal of the American Academy of Dermatology, 31(4), 1994, pp. 613-616